Zhao, Y., Guo, H., Niu, L., & Zhao, J. (2025, August). Metabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): Insights into Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) as a potential therapeutic target. Cancer pathogenesis and therapy. https://doi.org/10.1016/j.cpt.2025.08.002
Chicago Style (17th ed.) CitationZhao, Yijing, Hanfei Guo, Liting Niu, and Jinfang Zhao. "Metabolic Pathways and Chemotherapy Resistance in Acute Myeloid Leukemia (AML): Insights into Enoyl-CoA Hydratase Domain-containing Protein 3 (ECHDC3) as a Potential Therapeutic Target." Cancer Pathogenesis and Therapy Aug. 2025. https://doi.org/10.1016/j.cpt.2025.08.002.
MLA (9th ed.) CitationZhao, Yijing, et al. "Metabolic Pathways and Chemotherapy Resistance in Acute Myeloid Leukemia (AML): Insights into Enoyl-CoA Hydratase Domain-containing Protein 3 (ECHDC3) as a Potential Therapeutic Target." Cancer Pathogenesis and Therapy, Aug. 2025, https://doi.org/10.1016/j.cpt.2025.08.002.